---
figid: PMC9661392__gr8
pmcid: PMC9661392
image_filename: gr8.jpg
figure_link: /pmc/articles/PMC9661392/figure/fig0008/
number: Fig. 8
figure_title: ''
caption: TMEM100 inhibited prostate cancer progression by regulating the FAK/PI3K/AKT
  signaling pathway via SCNN1D.
article_title: Effect of transmembrane protein 100 on prostate cancer progression
  by regulating SCNN1D through the FAK/PI3K/AKT pathway.
citation: Zehua Ye, et al. Transl Oncol. 2023 Jan;27:101578.
year: '2023'

doi: 10.1016/j.tranon.2022.101578
journal_title: Translational Oncology
journal_nlm_ta: Transl Oncol
publisher_name: Neoplasia Press

keywords:
- Transmembrane protein 100
- Prostate cancer
- Progression
- FAK/PI3K/AKT pathway
- DAB, 3,3â€²-diaminobenzidine
- EMT, Epithelial-mesenchymal transition
- FAK, Focal adhesion kinase
- GEPIA, Gene Expression Profiling Interactive Analysis
- HRP, Horseradish peroxidase
- IHC, Immunohistochemistry
- OS, Overall survival
- P13K, Phosphatidylinositol-3-kinase
- PFS, Progression-free survival
- Pca, Prostate cancer
- STRING, Search tool for the retrieval of interacting genes/proteins
- SCNN1D, Sodium Channel Epithelial 1 Subunit Delta
- TMEM, Transmembrane

---
